Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences:

Event: Cowen 43rd Annual Healthcare Conference Location: Boston, MA Fireside Chat Date & Time: Tuesday, March 7, 2023 at 9:50am ET Presenter: Ying Huang, Ph.D., CEO

Event: Barclays Global Healthcare Conference Location: Miami, FL Fireside Chat Date & Time: Tuesday, March 14, 2023 at 10:15am ET Presenter: Ying Huang, Ph.D., CEO

About Legend Biotech Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at www.legendbiotech.com and follow us on Twitter and LinkedIn.

Press Contact: Tina Carter, Corporate Communications Lead, Legend Biotech tina.carter@legendbiotech.com (908) 331-5025

Investor Contacts: Joanne Choi, Senior Manager, Investor Relations, Legend Biotech joanne.choi@legendbiotech.com

Crystal Chen, Manager, Investor Relations, Legend Biotech crystal.chen@legendbiotech.com

Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Legend Biotech Charts.
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Legend Biotech Charts.